New drug combo aims to shrink liver tumors before surgeons operate
NCT ID NCT05908786
Summary
This study tested whether giving patients with operable liver cancer a short course of immune-boosting drug combinations before surgery could help shrink their tumors. The goal was to see if this 'neoadjuvant' approach could lead to better surgical outcomes and lower the chance of the cancer coming back. The trial involved 62 participants and was designed to test different drug combinations as they became available.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARCINOMA, HEPATOCELLULAR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Asan Medical Center
Seoul, 05505, South Korea
-
Assistance Publique-Hopitaux de Paris
Villejuif, 94800, France
-
Auckland District Health Board (ADHB)
Auckland, 1023, New Zealand
-
Barbara Ann Karmanos Cancer Institute - Karmanos Cancer Center - Main Campus
Detroit, Michigan, 48201-2013, United States
-
CHA Bundang Medical Center
Seongnam-si, Gyeonggi-do, 463-712, South Korea
-
Centre Eugene Marquis (CEM)
Rennes, 35042, France
-
Centre Georges Francois Leclerc (CGFL)
Dijon, 21079, France
-
Chang Gung Medical Foundation, Kaohsiung Chang Gung Memorial Hospital
Tainan, 83301, Taiwan
-
Clínica Universidad de Navarra
Pamplona, Navarre, 31620, Spain
-
Columbia University Medical Center
New York, New York, 10032, United States
-
Department of Internal Medicine III AKH and Medical University of Vienna
Vienna, 1180, Austria
-
Georgetown University Medical Center
Washington D.C., District of Columbia, 20007, United States
-
Gustave Roussy
Villejuif, 94800, France
-
Hospital Clinic de Barcelona (Hospital Clinic i Provincial)
Barcelona, 8036, Spain
-
Hospital Universitario Fundacion Jimenez Diaz.
Madrid, 28040, Spain
-
Hospital Universitario Marques de Valdecilla
Santander, Cantabria, 39008, Spain
-
Imperial College London - Imperial Centre for Translational and Experimental Medicine (ICTEM)
London, United Kingdom
-
Klinikum Klagenfurt am Wörthersee
Klagenfurt, 9020, Austria
-
National Cheng Kung University Hospital
Tainan, 70457, Taiwan
-
National Taiwan University Hospital (NTUH) - Cancer Research Center
Zhongzheng Dist., 10051, Taiwan
-
Severance Hospital, Yonsei University Health System
Seoul, 003-722, South Korea
-
Taichung Veterans General Hospital
Taichung, 40705, Taiwan
-
Taipei Veterans General Hospital
Taipei, 112, Taiwan
-
UT Southwestern Medical Center
Dallas, Texas, 75390-8813, United States
-
Universitaets Klinikum Frankfurt - Zentrum der Inneren Medizin
Frankfurt, 60596, Germany
-
Universitaetsmedizin der Johannes Gutenberg-Universitaet Mainz
Mainz, 55131, Germany
-
University Essen
Essen, 45147, Germany
-
University of California Los Angeles (UCLA) - Cancer Care - Santa Monica
Santa Monica, California, 90404-2023, United States
-
University of Southern California (USC)
Los Angeles, California, 90033, United States
-
Wiener Gesundheitsverbund, Klinik Favoriten
Vienna, 1100, Austria
Conditions
Explore the condition pages connected to this study.